Skip to main content
HR 1387 107th Congress House Health Access to health care Capitation (Medical care) Commerce Congress Congressional investigations Congressional reporting requirements Crime and Law Enforcement Drug adulteration Drug industry Drugs Finance and Financial Sector Foreign Trade and International Finance Fraud Government Operations and Politics Governmental investigations Health maintenance organizations Imports Insurance premiums Intellectual property

Drug Availability and Health Care Access Improvement Act of 2001

Introduced: April 4, 2001 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 25, 2001
Referred to the Subcommittee on Health.
Apr 24, 2001
Referred to the Subcommittee on Health.
Apr 4, 2001
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 4, 2001
Introduced in House
 Plain-English summary Congressional Research Service
Drug Availability and Health Care Access Improvement Act of 2001 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require State Medicaid plans to cover prescribed drugs for qualified Medicare (SSA title XVIII) and other low-income Medicare beneficiaries.

Provides full Federal funding for such Medicaid coverage.

Amends SSA title XVIII part C (Medicare+Choice), as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, with respect to access to Medicare+Choice plans through an increase in the minimum Medicare+Choice capitation rate.

Amends the Federal Food, Drug, and Cosmetic Act with respect to the program for importation of certain prescription drugs by pharmacists and wholesalers to: (1) revise importer drug testing requirements; (2) prohibit drug manufacturers from discriminating against U.S. pharmacists, wholesalers, or consumers; and (3) changes from the Secretary of Health and Human Services to the Comptroller General responsibility for a specified study on drug imports.

What's happening now April 25, 2001

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 1 Independent 1